Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) is a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical drug formulations, today announced that James Lewis, MD will present “Dropless Cataract Surgery” during the New Technologies Session of the American-European Congress of Ophthalmic Surgery (ACOS™). Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) stock opened at $8.06 in last session, and closed at $8.65, while the day range of IMMY stock is $8.06-$8.76.The stock showed a positive weekly performance of -16.82%.
Analysts at Cowen and Company lifted their target price on shares of LDR Holding Corp (NASDAQ:LDRH) from $25.00 to $34.00 in a research report issued to clients and investors on Friday,AnalystRatingsNetwork.com reports. Cowen and Company’s target price points to a potential upside of 17.89% from the company’s current price. LDR Holding Corp (NASDAQ:LDRH) stock opened at $31.39, in last session and closed at $31.25, by gained 8.36%.The 52 week range was $17.79-$31.59.Company’s market capitalization is $732.06 million.
CorMedix Inc. (NYSEMKT:CRMD) is a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announced that it has entered into securities purchase agreements with investors pursuant to which it has agreed to sell 200,000 shares of Series C-3 Non-Voting Convertible preferred stock and a warrant to purchase up to 1,000,000 shares of common stock for aggregate gross proceeds of $2,000,000. CorMedix Inc. (NYSEMKT:CRMD) stock gained 10.72% and finished the last session at $2.79.The EPS of the stock remained -0.51.Company’s market capitalization is $45.10 million.
Flexion Therapeutics Inc (NASDAQ:FLXN) announced (Feb. 26, 2014) that CEO Michael Clayman, M.D., will present an overview of the company at the 34th Annual Cowen Health Care Conference. Dr. Clayman’s presentation is scheduled for March 3, 2014, at 4:50 p.m. Eastern Time. The Conference will take place March 3-5, 2014, at The Boston Marriott Copley Place. Flexion Therapeutics Inc (NASDAQ:FLXN) stock opened the session at $16.01, and closed the session at $18.40.The 52 week range of the FLXN stock remained $14.05-$19.75 and the day range was $16.01-$19.75.